GSA Capital Partners’s Pulmonx LUNG Stock Holding History

GSA Capital Partners’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$177K	Sell	136,157 -1,331	-1%	-$1.83K	0.01%	1558
2026 Q1	$177K	Sell	137,488 -266,274	-66%	-$440K	0.01%	1481
2025 Q4	$892K	Sell	403,762 -351,705	-47%	-$661K	0.08%	433
2025 Q3	$1.22M	Buy	755,467 +331,742	+78%	+$694K	0.1%	281
2025 Q2	$1.1M	Buy	+423,725	New	+$1.67M	0.08%	396
2025 Q1	–	Sell	-85,809	Closed	-$583K	–	1903
2024 Q4	$583K	Buy	85,809 +21,038	+32%	+$139K	0.04%	772
2024 Q3	$537K	Buy	+64,771	New	+$469K	0.04%	855
2024 Q1	–	Sell	-19,792	Closed	-$252K	–	1819
2023 Q4	$252K	Buy	+19,792	New	+$206K	0.02%	1202
2023 Q1	–	Sell	-157,494	Closed	-$1.33M	–	1741
2022 Q4	$1.33M	Buy	+157,494	New	+$1.5M	0.16%	90

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

GSA Capital Partners's LUNG Position: Q2 2026 in Review

GSA Capital Partners reduced its Pulmonx (LUNG) stake by 0.97% in Q2 2026, selling an estimated $1.83K and leaving 136,157 shares worth $177K. The position accounts for 0.01% of the portfolio, ranked #1558.

GSA Capital Partners first reported a position in LUNG in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.33M in Q4 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

GSA Capital Partners held 136,157 shares of Pulmonx worth $177K as of Q2 2026.
GSA Capital Partners sold 1,331 Pulmonx shares in Q2 2026, an estimated $1.83K.
Pulmonx made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1558 holding.
GSA Capital Partners first reported a position in Pulmonx in Q4 2022 and has held it in 9 quarters since.
GSA Capital Partners's Pulmonx position peaked at $1.33M in Q4 2022.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.